NUWE
Price
$3.44
Change
+$0.02 (+0.58%)
Updated
Oct 17 closing price
Capitalization
3.11M
PRE
Price
$15.00
Change
-$0.86 (-5.42%)
Updated
Oct 17 closing price
Capitalization
195.51M
Interact to see
Advertisement

NUWE vs PRE

Header iconNUWE vs PRE Comparison
Open Charts NUWE vs PREBanner chart's image
Nuwellis
Price$3.44
Change+$0.02 (+0.58%)
Volume$47.17K
Capitalization3.11M
Prenetics Global
Price$15.00
Change-$0.86 (-5.42%)
Volume$73.48K
Capitalization195.51M
NUWE vs PRE Comparison Chart in %
NUWE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NUWE vs. PRE commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NUWE is a Hold and PRE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (NUWE: $3.44 vs. PRE: $15.00)
Brand notoriety: NUWE and PRE are both not notable
NUWE represents the Medical/Nursing Services, while PRE is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NUWE: 19% vs. PRE: 72%
Market capitalization -- NUWE: $3.11M vs. PRE: $195.51M
NUWE [@Medical/Nursing Services] is valued at $3.11M. PRE’s [@Medical Specialties] market capitalization is $195.51M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $223.72B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.65B. The average market capitalization across the [@Medical Specialties] industry is $11.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NUWE’s FA Score shows that 1 FA rating(s) are green whilePRE’s FA Score has 1 green FA rating(s).

  • NUWE’s FA Score: 1 green, 4 red.
  • PRE’s FA Score: 1 green, 4 red.
According to our system of comparison, PRE is a better buy in the long-term than NUWE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NUWE’s TA Score shows that 3 TA indicator(s) are bullish while PRE’s TA Score has 2 bullish TA indicator(s).

  • NUWE’s TA Score: 3 bullish, 4 bearish.
  • PRE’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, NUWE is a better buy in the short-term than PRE.

Price Growth

NUWE (@Medical/Nursing Services) experienced а -1.71% price change this week, while PRE (@Medical Specialties) price change was +7.99% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.22%. For the same industry, the average monthly price growth was +3.46%, and the average quarterly price growth was +18.56%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.25%. For the same industry, the average monthly price growth was +3.05%, and the average quarterly price growth was +51.76%.

Industries' Descriptions

@Medical/Nursing Services (+1.22% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Medical Specialties (+0.25% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRE($196M) has a higher market cap than NUWE($3.11M). PRE has higher P/E ratio than NUWE: PRE (1.06) vs NUWE (0.01). PRE YTD gains are higher at: 158.621 vs. NUWE (-92.621). NUWE has higher annual earnings (EBITDA): -3.84M vs. PRE (-59.21M). PRE has more cash in the bank: 58.5M vs. NUWE (4.45M). NUWE has less debt than PRE: NUWE (438K) vs PRE (5.15M). PRE has higher revenues than NUWE: PRE (41.5M) vs NUWE (8.32M).
NUWEPRENUWE / PRE
Capitalization3.11M196M2%
EBITDA-3.84M-59.21M6%
Gain YTD-92.621158.621-58%
P/E Ratio0.011.061%
Revenue8.32M41.5M20%
Total Cash4.45M58.5M8%
Total Debt438K5.15M9%
FUNDAMENTALS RATINGS
NUWE: Fundamental Ratings
NUWE
OUTLOOK RATING
1..100
1
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NUWEPRE
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
58%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
61%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
58%
Advances
ODDS (%)
Bullish Trend 16 days ago
80%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
58%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
46%
View a ticker or compare two or three
Interact to see
Advertisement
NUWE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OJIPY51.93N/A
N/A
Oji Holdings Corp
VODPF1.11N/A
N/A
Vodafone Group Plc
PBKC62.25N/A
N/A
Pioneer Bankcorp Inc.
COVCF12.70-0.30
-2.31%
COVER CORP.
BIXT0.07N/A
-4.87%
Bioxytran, Inc.

NUWE and

Correlation & Price change

A.I.dvisor tells us that NUWE and VAPO have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NUWE and VAPO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUWE
1D Price
Change %
NUWE100%
+0.58%
VAPO - NUWE
30%
Poorly correlated
N/A
CORBF - NUWE
24%
Poorly correlated
N/A
PRE - NUWE
24%
Poorly correlated
-5.42%
BNR - NUWE
23%
Poorly correlated
+0.13%
BVS - NUWE
22%
Poorly correlated
-3.20%
More

PRE and

Correlation & Price change

A.I.dvisor tells us that PRE and DSRLF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRE and DSRLF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRE
1D Price
Change %
PRE100%
-5.42%
DSRLF - PRE
25%
Poorly correlated
N/A
NUWE - PRE
24%
Poorly correlated
+0.58%
SHC - PRE
23%
Poorly correlated
-1.04%
PDEX - PRE
23%
Poorly correlated
+9.68%
IDXX - PRE
23%
Poorly correlated
-0.30%
More